Drugs / BM7PE
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT04550897 | Aug 2020 → Jun 2024 | colorectal cancer | Oslo University Hospital | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BM7PE | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04550897 ↗ |
| Modality | Protein / enzyme biologic | “BM7PE immunotoxin” NCT04550897 ↗ |
| Route | Intravenous | “administered as a 20-minute i.v. infusion.” NCT04550897 ↗ |